Moderna filed for Emergency Use Authorization for its COVID-19 vaccine in adolescents in the United States
On Jun. 10, 2021, Moderna announced that it had requested an emergency use authorization (EUA) for its COVID-19…
-
-
Pfizer and BioNTech provided 500 million doses of COVID-19 vaccine to U.S. Government for donation to poorest nations
On Jun. 10, 2021, Pfizer and BioNTech announced plans to provide the U.S. government at a not-for-profit price…
-
Merck announced supply agreement with U.S. Government for molnupiravir, an Investigational oral antiviral treatment of COVID-19
On Jun. 9, 2021, Merck announced it had entered into a procurement agreement with the United States government…
-
Vertex announces FDA approval for TRIKAFTA in children with Cystic Fibrosis ages 6 through 11 with certain mutations
On Jun. 9, 2021, Vertex Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approved expanded use of…
-
Roche obtained CE mark for SARS-CoV-2 antigen self test nasal allowing for rapid self testing of COVID-19 at home
On Jun. 8, 2021, Roche announced it had received CE mark for its SARS-CoV-2 Antigen Self Test Nasal…
-
RECOVERY trial found aspirin does not improve survival for patients hospitalised with COVID-19
On Jun. 8, 2021, the University of Oxford announced the RECOVERY trial was established as a randomised clinical…
-
Senolytics reduced COVID-19 symptoms in preclinical studies
On Jun. 8, 2021, Mayo Clinic researchers and colleagues at the University of Minnesota showed that COVID-19 exacerbates…
-
FDA approved PREVNAR 20, Pfizer’s pneumococcal 20-valent conjugate vaccine for adults ages 18 years or older
On Jun. 8, 2021, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PREVNAR 20…
-
Pixel by Labcorp COVID-19 PCR test home collection kits now available nationwide
On Jun. 8, 2021, LabCorp announced that its Pixel COVID-19 PCR Test Home Collection Kits were availavle in…
-
Twist Bioscience began shipping of synthetic RNA controls for Kappa (B.1.617.1) SARS-CoV-2 variants
On Jun. 8, 2021, Twist Bioscience announced that it has started shipping its synthetic RNA reference controls for…
-
INOVIO expanded partnership with Advaccine to conduct global phase 3 efficacy trial of COVID-19 DNA vaccine candidate
On Jun. 8, 2021, Inovio Pharma announced an expansion of its previously announced partnership with Advaccine Biopharmaceuticals to…
-
Study suggested no association between antiseizure drugs used during pregnancy and neurodevelopmental problems in children at age 2
On Jun. 7, 2021, the National Institutes of Health announced new findings published in JAMA Neurology that suggested…
-
MediciNova initiated sheep study under BARDA to develop MN-166 (ibudilast) as countermeasure against chlorine
On Jun. 7, 2021, MediciNova announced it had initiated a sheep study to investigate MN-166 (ibudilast) in an…
-
Biotechnology | Disease | FDA | Neurology | Therapeutics
FDA granted accelerated approval for ADUHELM as the first and only Alzheimer’s disease treatment
On Jun. 7, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
-
Moderna applied for EU coronavirus vaccine authorization covering teens
On Jun. 7, 2021, Moderna announced announced that it had submitted for a variation to the conditional marketing…
-
OraSure Technologies receives three EUA’s for its COVID-19 rapid antigen tests for non-prescription use
On Jun. 7, 2021, OraSure Technologies announced that it had received Emergency Use Authorization (EUA) from the U.S….
-
Moderna and Medison Pharma partnered to commercialize COVID-19 vaccine in Central Eastern Europe and Israel
On Jun. 7, 2021, Moderna announced a new agreement to commercialize its COVID-19 Vaccine across Central Eastern Europe…
-
FDA approved new rug treatment for chronic weight management, first since 2014
On Jun. 4, 2021, the U.S. Food and Drug Administration (FDA) announced it had approved Novo Nordisk’s Wegovy…
-
Chimerix received U.S. FDA approval for TEMBEXA (brincidofovir) for treatment of smallpox
On Jun. 4, 2021, The U.S. Food and Drug Administration (FDA) approved Chimerix’s Tembexa (brincidofovir) tablets and oral…
-
FDA authorized lower 1,200 mg intravenous and subcutaneous dose of REGEN-COV antibody cocktail to treat COVID-19 patients
On Jun. 4, 2021, Regeneron announced the U.S. Food and Drug Administration (FDA) updated the Emergency Use Authorization…
-
Resverlogix and EVERSANA announced partnership to support commercialization of Apabetalone for COVID-19 in U.S. and Canada
On Jun. 3, 2021, Resverlogix announced a partnership to support planned commercialization of apabetalone in the United States…
-
NIH researchers identified potential new antiviral drug for COVID-19
On Jun. 3, 2021, the National Institutes of Health (NIH) announced that the experimental drug TEMPOL may be…
-
Moderna announced agreement to supply the Republic of Botswana with COVID-19 vaccine
On Jun. 3, 2021, Moder’s vaccine against COVID-19, to support the government’s ongoing efforts to secure access to…
-
Innovation Pharma completed enrollment in phase 2 clinical trial for COVID-19
On Jun. 3, 2021, Innovation Pharma announced that it had achieved full patient enrollment in its randomized, double-blind,…
-
UNICEF and Moderna announced long term agreement to supply vaccine on behalf of the COVAX facility
On Jun. 2, 2021, UNICEF announced it had signed a long-term agreement with Moderna for the supply of COVID-19 vaccine on behalf of the…
-
Lonza and Moderna announced collaboration for drug substance manufacturing of COVID-19 Vaccine in the Netherlands
On Jun. 2, 2021, Lonza announced the expansion of its collaboration with Moderna. The expanded collaboration extended the…
-
Vaxxas and collaborators revealed potential of Vaxxas’ high-density microarray patch to deliver SARS-CoV-2 vaccine
On Jun. 2, 2021, Vaxxas announced that research demonstrated the potential of Vaxxas’ novel high-density microarray patch (HD-MAP)…
-
Moderna announced rolling submission of Biologics License Application with FDA for COVID-19 vaccine
On Jun. 1, 2021, Moderna announced that it had initiated the rolling submission process with the U.S. Food…
-
AquaBounty received approval for the sale of GE Atlantic Salmon in Brazil
On Jun. 1, 2021, AquaBounty Technologies announced the successful completion of the first commercial scale harvest of its…
-
CytoDyn received first order from Chiral Pharma for use of Leronlimab for COVID-19 patients in the Philippines
On Jun. 1, 2021, CytoDyn announced that Chiral Pharma in the Philippines placed its first purchase order for…
